Clinical Trials
for Alzheimer's in Indiana
19 clinical trials for Alzheimer's are currently recruiting participants at study sites in Indiana. Study-related care is provided at no cost.
Alzheimer's clinical trials in Indiana: what to expect
Alzheimer's trials now span the whole course of the disease. Prevention studies enroll people with normal memory who have early signs of amyloid in the brain; treatment studies enroll people with mild cognitive impairment or early Alzheimer's and test the next generation of antibodies, tau-targeting drugs and combinations; and symptom studies address agitation, sleep and depression in later stages. Alongside drugs there are trials of exercise, cognitive training, blood tests for diagnosis and support programs for care partners.
In Indiana, recruiting alzheimer's studies are concentrated in Indianapolis, Bloomington, Fort Wayne and Nationwide. 7 of the 19 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.
Who Alzheimer's trials usually look for
Most drug trials enroll ages 50 to 85 and define a stage with a memory test score range, then confirm Alzheimer's with an amyloid PET scan, a spinal fluid test or, increasingly, a blood test, all done by the study. Nearly every trial requires a study partner: someone who knows you well, attends visits and answers questions about daily life. Common exclusions are another cause of memory loss, a recent stroke and, for antibody trials, some blood thinners or MRI findings. Prevention trials enroll people with no symptoms at all.
What taking part involves
Screening is longer than for most conditions, often several visits over a few weeks with memory testing, an MRI and an amyloid test. Antibody trials then involve an infusion or injection every two to four weeks, regular safety MRIs and visits for eighteen months to four years, with an extension in which everyone receives the drug. Lifestyle trials involve classes or coaching for six to twenty-four months. All study care is free and travel is usually reimbursed for you and your partner.
Questions worth asking the study team
Whether you will be told your amyloid or genetic results; what the MRI safety monitoring involves; how much time the study partner must give; whether there is an extension after the placebo period; and what happens if memory worsens during the study.
Showing 19 of 19 recruiting Alzheimer's trials in Indiana
Where the Alzheimer's studies are in Indiana
- Clinical Trial Site, Indianapolis2 trials
- Indiana University, Indianapolis2 trials
- Indiana University School of Medicine, Indianapolis2 trials
- Josephson Wallack Munshower Neurology, PC, Indianapolis2 trials
- Care Access - South Indianapolis, Indianapolis1 trial
- Community Health Network, Indianapolis1 trial
Counts are recruiting studies listing at least one site in Indiana, from ClinicalTrials.gov, refreshed every two days.
Alzheimer's clinical trials in Indiana: common questions
Check Your Eligibility
Create a free profile and our AI will match you to Alzheimer's trials near you in Indiana.
Get Matched — FreeAlzheimer's disease trials test amyloid-clearing antibodies, tau inhibitors, lifestyle interventions, and early-detection biomarkers for dementia prevention and treatment.
All Alzheimer's trials →